“… 14 , 15 , 16 , 17 Among these effector functions, ADCP has been shown to correlate with immune protection against several RNA viruses, including HIV, 18 ebola, 19 dengue, 20 and influenza. 21 Importantly, in patients with HIV infection, antibodies that neutralize broader HIV variants 22 , 23 also possess potent Fc receptor‐dependent effector functions, including ADCP, 24 , 25 and antibodies that maintain broadly neutralizing function at later stages of the disease showed an early and stronger Fc‐receptor‐dependent effector function. 14 , 17 , 26 , 27 A positive relationship between neutralization and ADCP was also observed in patients with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) 15 , 28 and influenza virus 29 infections.…”